Top

Published in:

01-03-2011

Recommendations for Enhancing Clinical Trials Education: a Review of the Literature

Authors: Karen A. Stepan, Amy P. Gonzalez, Vivian S. Dorsey, Debra K. Frye, Nita D. Pyle, Regina F. Smith, Terry A. Throckmorton, Louise A. Villejo, Scott B. Cantor

Published in: Journal of Cancer Education | Issue 1/2011

Abstract

This study aims to apply the evidence-based practice (EBP) process to determine the factors that influence patients’ understanding of, participation in, and satisfaction with clinical trials, the informed consent process, and treatment decisions and to make recommendations for improving clinical trials education. Beginning with evidence retrieval, the authors identified key search terms and searched MEDLINE—Ovid, MEDLINE—PubMed, and the Cumulative Index to Nursing and Allied Health Literature to identify articles published between July 2001 and July 2006 that highlighted clinical trials education. The articles were reviewed for clinical trials patient education information, clinician methods of communicating clinical trial information to patients, and patient satisfaction with the clinical trials process, including the informed consent process. As a result, practice changes were recommended for the patient/family, staff/community, and institution. From the literature review, 81 articles were identified. Recurring themes included decision-making, patient education, staff education, and pediatrics. Most articles focused on methods and strategies aimed at improving education at the patient/family, staff/community, and institutional levels. The issues surrounding clinical trial education are complex due to multiple variables interfering with poor patient understanding of, participation in, and satisfaction with clinical trial treatment decisions. On the basis of our findings, we recommend that clinicians involved in educating patients, families, staff, and communities about clinical trials have an awareness of and understanding for very complex issues.

Aapro MS, Kohne C-H, Cohen HJ, Extermann M (2005) Never too old? Age should not be a barrier to enrollment in cancer clinical trials. Oncologist 10(3):198–204CrossRefPubMed

Advani AS, Atkeson B, Brown CL, Peterson BL, Fish L, Johnson JL, Gockerman JP, Gautier M (2003) Barriers to the participation of African–American patients with cancer in clinical trials: a pilot study. Cancer 97(6):1499–1506CrossRefPubMed

Agrawal M, Emanuel EJ (2003) Ethics of phase 1 oncology studies: reexamining the arguments and data. J Am Med Assoc 290(8):1075–1082CrossRef

Albrecht TL, Franks MM, Ruckdeschel JC (2005) Communication and informed consent. Curr Opin Oncol 17(4):336–339CrossRefPubMed

Albrecht TL, Ruckdeschel JC, Riddle DL, Blanchard CG, Penner LA, Coovert MD, Quinn G (2003) Communication and consumer decision making about cancer clinical trials. Patient Educ Couns 50(1):39–42PubMed

Angiolillo AL, Simon C, Kodish E, Lange B, Noll RB, Ruccione K, Matloub Y (2004) Staged informed consent for a randomized clinical trial in childhood leukemia: impact on the consent. Pediatr Blood Cancer 42(5):433–437CrossRefPubMed

Avis NE, Smith KW, Link CL, Hortobagyi GN, Rivera E (2006) Factors associated with participation in breast cancer treatment clinical trials. J Clin Oncol 24(12):1860–1867CrossRefPubMed

Barrett R (2005) Quality of informed consent: measuring understanding among participants in oncology clinical trials. Oncol Nurs Forum 32(4):751–755CrossRefPubMed

Beskow LM, Sandler RS, Millikan RC, Weinberger M (2005) Patient perspectives on research recruitment through cancer registries. Cancer Causes Control 16(10):1171–1185CrossRefPubMed

10.

Broome ME, Richards DJ (2003) The influence of relationships on children’s and adolescents’ participation in research. Nurs Res 52(3):191–197CrossRefPubMed

11.

Brundage M, Leis A, Bezjak A, Feldman-Stewart D, Degner L, Velji K, Zetes-Zanatta L, Tu D, Ritvo P, Pater J (2003) Cancer patients’ preferences for communicating clinical trial quality of life information: a qualitative study. Qual Life Res 12(4):395–404CrossRefPubMed

12.

Burhansstipanow L, Krebs LU, Bradley A, Gamito E, Osborn K, Dignan MB, Kaur JS (2003) Lessons learned while developing “Clinical Trials Education for Native Americans” curriculum. Cancer Control 1(5 Suppl):29–36

13.

Burnet K, Benson J, Earl H, Thornton H, Cox K, Purushotham AD (2004) A survey of breast cancer patients’ views on entry into several clinical studies. Eur J Cancer Care 13(1):32–35CrossRef

14.

Casarett D, Karlawish J, Sankar P, Hirschman KB, Asch DA (2002) Obtaining informed consent for cancer pain research: do patients with advanced cancer and patients with chronic pain have different concerns? J Pain Symptom Manage 24(5):506–516CrossRefPubMed

15.

Chang SM, Barker FG, Schmidt MH, Sloan AE, Kasper R, Phillips L, Shih K, Hariharan S, Berger MS (2002) Clinical trial participation among patients enrolled in the Glioma Outcomes Project. Cancer 94(10):2681–2687CrossRefPubMed

16.

Connolly NB, Schneider D, Hill AM (2004) Improving enrollment in cancer clinical trials. Oncol Nurs Forum 31(3):610–614CrossRefPubMed

17.

Cox K (2002) Informed consent and decision making: patients’ experiences of the recruitment to phases I and II anti-cancer drug trials. Patient Educ Couns 46(1):31–38CrossRefPubMed

18.

Cox K, McGarry J (2003) Why patients don’t take part in cancer clinical trials: an overview of the literature. Eur J Cancer Care 12(2):114–122CrossRef

19.

Coyne CA, Xu R, Raich P, Plomer K, Dignan M, Wenzel LB, Fairclough D, Habermann T, Schnell L, Quella S, Cella D (2003) Eastern Cooperative Oncology Group. Randomized, controlled trial of an easy-to-read informed consent statement for clinical trial participation: a study of the Eastern Cooperative Oncology Group. J Clin Oncol 21(5):836–842CrossRefPubMed

20.

Curbow B, Fogarty LA, McDonnell K, Chill J, Scott LB (2004) Can a brief video intervention improve breast cancer clinical trial knowledge and beliefs? Soc Sci Med 58(1):193–205CrossRefPubMed

21.

Daugherty CK, Fitchett G, Murphy PE, Peterman AH, Banik DM, Hlubocky F, Tartaro J (2005) Trusting God and medicine: spirituality in advanced cancer patients volunteering for clinical trials of experimental agents. Psycho-Oncology 14(2):135–146CrossRefPubMed

22.

Deatrick JA, Angst DB, Moore C (2002) Patients’ views of their children’s participation in phase I oncology clinical trials. J Pediatr Oncol Nurs 19(4):114–121CrossRefPubMed

23.

Ehrenberger H (2001) Cancer clinical trial patients in the information age: a pilot study. Cancer Pract 9(4):191–197CrossRefPubMed

24.

Eiser C, Davies H, Jenney M, Glaser A (2005) Mothers’ attitudes to the randomized controlled trial (RCT): the case of acute lymphoblastic leukemia (ALL) in children. Child Care Health Dev 31(5):517–523CrossRefPubMed

25.

Ellis PM, Butow PN, Tattersall MHN (2002) Informing breast cancer patients about clinical trials: a randomized clinical trial of an educational booklet. Ann Oncol 13(9):1414–1423CrossRefPubMed

26.

Ellis PM, Butow PN, Tattersall MH, Dunn SM, Houssami N (2001) Randomized clinical trials in oncology: understanding and attitudes predict willingness to participate. J Clin Oncol 19(15):3554–3561PubMed

27.

Ford JG, Howerton MW, Bolen S, Gary TL, Lai GY, Tilburt J, Gibbons MC, Baffi C, Wilson RF, Feuerstein CJ, Tanpitukpongse P, Powe NR, Bass EB (2005) Knowledge and access to information on recruitment of underrepresented populations to cancer clinical trials. Evid Rep Technol Assess Summ 122:1–11PubMed

28.

Gaston CM, Mitchell G (2005) Information giving and decision-making in patients with advanced cancer: a systematic review. Soc Sci Med 61(10):2252–2264CrossRefPubMed

29.

Gattellari M, Voigt KJ, Butow PN, Tattersall MHN (2002) When the treat goal is not cure: are cancer patients equipped to make informed decisions? J Clin Oncol 20(2):503–513CrossRefPubMed

30.

Horng S, Grady C (2003) Misunderstanding in clinical research: distinguishing therapeutic misconception, therapeutic misestimation, and therapeutic optimism. IRB 25(1):11–16CrossRefPubMed

31.

Hutchison C, Campbell S (2002) Evaluation of an information booklet for patients considering participation in phase I clinical trials in cancer. Eur J Cancer Care 11(2):131–138CrossRef

32.

Jenkins V, Leach L, Fallowfield L, Nicholls K, Newsham A (2002) Describing randomization: patients’ and the public’s preferences compared with clinicians’ practice. Br J Cancer 87(8):854–858CrossRefPubMed

33.

Joffe S, Cook EF, Cleary PD, Clark JW, Weeks JC (2001) Quality of informed consent: a new measure of understanding among research subjects. J Natl Cancer Inst 93(2):139–147CrossRefPubMed

34.

Joffe S, Cook EF, Cleary PD, Clark JW, Weeks JC (2001) Quality of informed consent in cancer clinical trials: a cross-sectional survey. Lancet 358(9295):1772–1177CrossRefPubMed

35.

Kelly C, Ghazi F, Caldwell K (2002) Psychological distress of cancer and clinical trial participation: a review of the literature. Eur J Cancer Care 11(1):6–15CrossRef

36.

Kornblith AB, Kemeny M, Peterson BL, Wheeler J, Crawford J, Bartlett N, Fleming G, Graziano S, Muss H, Cohen HJ (2002) Cancer and Leukemia Group B. Survey of oncologists’ perceptions of barriers to accrual of older patients with breast carcinoma to clinical trials. Cancer 95(5):989–996CrossRefPubMed

37.

Kupst MJ, Patenaude AF, Walco GA, Sterling C (2003) Clinical trials in pediatric cancer: parental perspectives on informed consent. J Pediatr Hematol/Oncol 25(10):787–790CrossRef

38.

Lara PN, Paterniti DA, Chiechi C, Turrell C, Morain C, Horan N, Montell L, Gonzalez J, Davis S, Umutyan A, Martel CL, Gandara DR, Wun T, Beckett LA, Chen MS (2005) Evaluation of factors affecting awareness of and unwillingness to participate in cancer clinical trials. J Clin Oncol 23(36):9282–9289CrossRefPubMed

39.

Lin JS, Finlay A, Tu A, Gany FM (2005) Understanding immigrant Chinese Americans’ participation in cancer screening and clinical trials. J Community Health 30(6):451–466CrossRefPubMed

40.

Lobiondo-Wood G, Haber J (2006) Nursing research: methods and critical appraisal for evidence-based practice. Mosby, St. Louis

41.

Mandelblatt J, Kaufman E, Sheppard VB, Pomeroy J, Kavanaugh J, Canar J, Pallandre L, Cullen J, Huerta E (2005) Breast cancer prevention in community clinics: will low-income Latina patients participate in clinical trials? Prev Med 40(6):611–618CrossRefPubMed

42.

Mannel RS, Walker JL, Gould N, Scribner DR, Kamelle S, Tillmanns T, McMeekin DS, Gold MA (2003) Impact of individual physicians on enrollment of patients into clinical trials. Am J Clin Oncol 26(2):171–173CrossRefPubMed

43.

Markman M (2006) Providing research participants with findings from completed cancer-related clinical trials: not quite as simple as it sounds. Cancer 106(7):1421–1424CrossRefPubMed

44.

Markman M, Markman MR, Belland A, Petersen J (2006) Profile of ovarian cancer patients seeking information from a web-based decision support program. J Women’s Health 15(3):312–318CrossRef

45.

Markman M, Petersen J, Montgomery R (2005) An examination of characteristics of lung and colon cancer patients participating in a web-based decision support program. Oncology 69(4):311–316CrossRefPubMed

46.

Martel CL, Li Y, Beckett L, Chew H, Christensen S, Davies A, Lam KS, Lau DH, Meyers FJ, O’Donnell RT, Richman C, Scudder S, Tanaka M, Tuscano J, Welborn J, Wun T, Gandara DR, Lara PN (2004) An evaluation of barriers to accrual in the era of legislation requiring insurance coverage of cancer clinical trial costs in California. Cancer J 10(5):294–300CrossRefPubMed

47.

Massimo LM, Wiley TJ, Casari EF (2004) From informed consent to shared consent: a developing process in pediatric oncology. Lancet Oncol 5(6):384–387CrossRefPubMed

48.

McCray AT, Ide NC, Loane RR, Tse T (2004) Strategies for supporting consumer health information seeking. Medinfo 11(Pt 2):1152–1156

49.

McPherson CJ, Higginson IJ, Hearn J (2001) Effective methods of giving information in cancer: a systematic literature review of randomized controlled trials. J Public Health Med 23(3):227–234CrossRefPubMed

50.

McTiernan A (2003) Issues surrounding the participation of adolescents with cancer in clinical trials in the UK. Eur J Cancer Care 12(3):233–239CrossRef

51.

Melisko ME, Hassin F, Metzroth L, Moore DH, Brown B, Patel K, Rugo HS, Tripathy D (2005) Patient and physician attitudes toward breast cancer clinical trials: developing interventions based on understanding barriers. Clin Breast Cancer 6(1):45–54CrossRefPubMed

52.

Menikoff J (2005) Full disclosure: telling patients when not being a research subject is a good choice. Perspect Biol Med 48(1 Suppl):S139–S149PubMed

53.

Meropol NJ, Weinfurt KP, Burnett CB, Balshem A, Benson AB, Castel L, Corbett S, Diefenbach M, Gaskin D, Li Y, Manne S, Marshall J, Rowland JH, Slater E, Sulmasy DP, Van Echo D, Washington S, Schulman KA (2003) Perceptions of patients and physicians regarding phase I cancer clinical trials: implications for physician–patient communication. J Clin Oncol 21(13):2589–2596CrossRefPubMed

54.

Miller VA, Drotar D, Burant C, Kodish E (2005) Clinician–parent communication during informed consent for pediatric leukemia trials. J Pediatr Psychol 30(3):219–229CrossRefPubMed

55.

Mills N, Donovan JL, Smith M, Jacoby A, Neal DE, Hamdy FC (2003) Perceptions of equipoise are crucial to trial participation: a qualitative study of men in the ProtecT study. Control Clin Trials 24(3):272–282CrossRefPubMed

56.

Mills EJ, Seely D, Rachlis B, Griffith L, Wu P, Wilson K, Ellis P, Wright JR (2006) Barriers to participation in clinical trials of cancer: a meta-analysis and systematic review of patient-reported factors. Lancet Oncol 7(2):141–148CrossRefPubMed

57.

Moore S (2001) A need to try everything: patient participation in phase I trials. J Adv Nurs 33(6):738–747CrossRefPubMed

58.

Nguyen TT, Somkin CP, Ma Y (2005) Participation of Asian–American women in cancer chemoprevention research: physician perspectives. Cancer 104(12 Suppl):3006–3014CrossRefPubMed

59.

Northouse LL, Rosset T, Phillips L, Mood D, Schafenacker A, Kershaw T (2006) Research with families facing cancer: the challenges of accrual and retention. Res Nurs Health 29(3):199–211CrossRefPubMed

60.

Nurgat ZA, Craig W, Campbell NC, Bissett JD, Cassidy J, Nicolson MC (2005) Patient motivations surrounding participation in phase I and phase II clinical trials of cancer chemotherapy. Br J Cancer 92(6):1001–1005CrossRefPubMed

61.

Olechnowicz JQ, Eder M, Simon C, Zyzanski S, Kodish E (2002) Assent observed: children’s involvement in leukemia treatment and research discussions. Pediatrics 109(5):806–814CrossRefPubMed

62.

Oppenheim D, Geoerger B, Hartmann O (2005) Ethical issues in pediatric oncology phase I–II trials based on a mother’s point of view. Bull Cancer 92(11):E57–E60PubMed

63.

Paradiso A, Bruno M, Cicoria O, Digennaro M, Longo S, Rinaldi M, Schittulli F (2004) Analysis of the reasons for accepting or declining participation in genetic research for breast cancer: a hospital-based population study. Tumori 90(4):435–436PubMed

64.

Partridge AH, Wong JS, Knudsen K, Gelman R, Sampson E, Gadd M, Bishop KL, Harris JR, Winer EP (2005) Offering participants results of a clinical trial: sharing results of a negative study. Lancet 365(9463):963–964CrossRefPubMed

65.

Paterniti DA, Chen MS, Chiechi C, Beckett LA, Horan N, Turrell C, Smith L, Morain C, Montell L, Luis Gonzalez J, Davis S, Lara PN (2005) Asian Americans and cancer clinical trials: a mixed-methods approach to understanding awareness and experience. Cancer 104(12 Suppl):S3015–S3024CrossRef

66.

Pentz RD, Billot L, Wendler D (2006) Research on stored biological samples: views of African American and White American cancer patients. Am J Med Genet A 140(7):733–739PubMed

67.

Pentz RD, Flamm AL, Sugarman J, Cohen MZ, Daniel Ayers G, Herbst RS, Abbruzzese JL (2002) Study of the media’s potential influence on prospective research participants’ understanding of and motivations for participation in a high-profile phase I trial. J Clin Oncol 20(18):3785–3791CrossRefPubMed

68.

Richards MPM, Ponder M, Pharoah P, Everest S, Mackay J (2003) Issues of consent and feedback in a genetic epidemiological study of women with breast cancer. J Med Ethics 29(2):93–96CrossRefPubMed

69.

Schaefer KM, Ladd E, Gergits MA, Gyauch L (2001) Backing and forthing: the process of decision making by women considering participation in a breast cancer prevention trial. Oncol Nurs Forum 28(4):703–709PubMed

70.

Scott JT, Prictor MJ, Harmsen M, Broom A, Entwistle V, Sowden A, Watt I (2003) Interventions for improving communication with children and adolescents about their cancer. Cochrane Database Syst Rev 3:1–33

71.

Simon CM, Kodish ED (2005) Step into my zapatos, doc: understanding and reducing communication disparities in the multicultural informed consent setting. Perspect Biol Med 48(1 Suppl):S123–S138PubMed

72.

Sorenson JB, Rossel P, Holm S (2004) Patient–physician communication concerning participation in cancer chemotherapy trials. Br J Cancer 90(2):328–332CrossRef

73.

Stevens T, Ahmedzai SH (2004) Why do breast cancer patients decline entry into randomized trials and how do they feel about their decision later: a prospective, longitudinal, in-depth interview study. Patient Educ Couns 52(3):341–348CrossRefPubMed

74.

Tattersall MHN, Gattellari M, Voigt K, Butow PN (2002) When the treatment goal is not cure: are patients informed adequately? Support Care Cancer 10(4):314–321CrossRefPubMed

75.

Thorne S, Hislop TG, Kuo M, Armstrong EA (2006) Hope and probability: patient perspectives of the meaning of numerical information in cancer communication. Qual Health Res 16(3):318–336CrossRefPubMed

76.

Townsley CA, Selby R, Siu LL (2005) Systematic review of barriers to the recruitment of older patients with cancer onto clinical trials. J Clin Oncol 23(13):3112–3124CrossRefPubMed

77.

Tu S-P, Chen H, Chen A, Lim J, May S, Drescher C (2005) Clinical trials: understanding and perceptions of female Chinese–American cancer patients. Cancer 104(12 Suppl):S2999–S3005CrossRef

78.

Weinfurt KP, Castel LD, Li Y, Sulmasy DP, Balshem AM, Benson AB, Burnett CB, Gaskin DJ, Marshall JL, Slater EF, Schulman KA, Meropol NJ (2003) The correlation between patient characteristics and expectations of benefit from phase I clinical trials. Cancer 98(1):166–175CrossRefPubMed

79.

Weinfurt KP, Depuy V, Castel LD, Sulmasy DP, Schulman KA, Meropol NJ (2005) Understanding of an aggregate probability statement by patients who are offered participation in phase I clinical trials. Cancer 103(1):140–147CrossRefPubMed

80.

Weinfurt KP, Sulmasy DP, Schulman KA, Meropol NJ (2003) Patient expectations of benefit from phase I clinical trials: linguistic considerations in diagnosing a therapeutic misconception. Theor Med Bioeth 24(4):329–344CrossRefPubMed

81.

Wendler D, Kington R, Madans J, Van Wye G, Christ-Schmidt H, Pratt LA, Brawley OW, Gross CP, Emanuel E (2006) Are racial and ethnic minorities less willing to participate in health research? PLoS Med/Public Library of Science 3(2):e19CrossRef

82.

Wright JR, Whelan TJ, Schiff S, Dubois S, Crooks D, Haines PT, DeRosa D, Roberts RS, Gafni A, Pritchard K, Levine MN (2004) Why cancer patients enter randomized clinical trials: exploring the factors that influence their decision. J Clin Oncol 22(21):4312–4318CrossRefPubMed

Title: Recommendations for Enhancing Clinical Trials Education: a Review of the Literature
Authors: Karen A. Stepan
Amy P. Gonzalez
Vivian S. Dorsey
Debra K. Frye
Nita D. Pyle
Regina F. Smith
Terry A. Throckmorton
Louise A. Villejo
Scott B. Cantor
Publication date: 01-03-2011
Publisher: Springer-Verlag
Published in: Journal of Cancer Education / Issue 1/2011
Print ISSN: 0885-8195
Electronic ISSN: 1543-0154
DOI: https://doi.org/10.1007/s13187-010-0160-4

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2011

Challenges of Recruiting ESL Immigrants into Cancer Education Studies: Reflections from Practice Notes

The Continuing Umbrella of Research Experiences (CURE): A Model for Training Underserved Scientists in Cancer Research

Evaluating the Knowledge of Breast Cancer Screening and Prevention among Arab-American Women in Michigan

Scientific English: A Program for Addressing Linguistic Barriers of International Research Trainees in the United States

Predicting Breast and Colon Cancer Screening Among English-as-a-Second-Language Older Chinese Immigrant Women to Canada

The Impact of Socioeconomic Status on the Breast Cancer Journey

Keynote webinar | Spotlight on antibody–drug conjugates in cancer